Skip to search.
 FTSE 100 Down 0.58%

VIVUS Inc. (VVUS)

-NasdaqGS
2.57 Up 0.08(3.21%) 27 Mar 20:00
|After Hours: : 2.52 Down 0.05 (1.95%) 27 Mar 22:04
Add to Portfolio
Prev Close:2.49
Open:2.51
Bid:2.11 x 200
Ask:2.57 x 1200
1y Target Est:4.00
Beta:1.1
Earnings Date:4 May - 8 May (Est.)
Day's Range:2.50 - 2.61
52wk Range:2.41 - 6.28
Volume:1,859,392
Avg Vol (3m):2,555,510
Market Cap:266.98m
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSUp 3.21%266.98m
LLYUp 0.19%78.04b
GSKUp 0.77%113.11b
PFEUp 1.08%211.63b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.13
Quarterly EPS Est (Mar-15) :-0.22
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):-0.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback